FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387433067> ?p ?o ?g. }

• W4387433067 endingPage "2300517" @default.
• W4387433067 startingPage "2300517" @default.
• W4387433067 abstract "Three treatment options have been successfully developed for the management of chronic thromboembolic pulmonary hypertension (CTEPH): pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA) and pulmonary arterial hypertension (PAH)-targeted medical therapy [1–3]. Management of CTEPH has greatly evolved in the last decade with the possibility to combine these therapeutic options [4, 5]. PEA is the recommended first-line treatment for operable patients [1–3]. However, despite continued improvement in the surgical technique, PEA remains a challenging surgery. This is particularly the case in patients with elevated pulmonary vascular resistance (PVR) as several studies have previously shown that high preoperative PVR was associated with an increase in early post-operative mortality [6–10]. Thus, Tromeur et al . have shown a markedly higher mortality in operated patients with pre-operative PVR of >800 dyn·s·cm−5 [10]. Additionally, some patients may have mixed anatomical lesions where surgically accessible lesions are present in one lung and surgically inaccessible lesions in the contralateral lung. We hypothesized that these patients may be suitable candidates for a sequential multimodal therapy consisting at first of PAH-targeted medical therapy to treat microvasculopathy, then BPA for surgically inaccessible lesions in one lung, and lastly PEA for the surgically accessible lesions in the contralateral lung. Footnotes This manuscript has recently been accepted for publication in the European Respiratory Journal . It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article. Conflict of Interest: Philippe Brenot reports lecture honoraria from MSD, outside the submitted work. Conflict of Interest: David Montani reports grants from Acceleron, Janssen, MSD; consulting fees from Acceleron; lecture honoraria from Bayer, Janssen, MSD; outside the submitted work. Conflict of Interest: Laurent Savale reports grants from Acceleron, Janssen, MSD; lecture honoraria from Janssen, MSD; travel support from Janssen; outside the submitted work. Conflict of Interest: Olivier Sitbon reports grants from Acceleron, Janssen, MSD, GSK; consulting fees from Gossamer Bio, Janssen, MSD; lecture honoraria from AOP Orphan, Janssen, Ferrer, MSD; travel support from Janssen; advisory board participation from Acceleron, Janssen, MSD; outside the submitted work. Conflict of Interest: Athénaïs Boucly reports grants from Acceleron, Janssen and MSD, payment or honoraria for lectures, manuscript writing or educational events from Janssen, Merck and AOP Orphan, and support for attending meetings and/or travel from Janssen. Conflict of Interest: Elie Fadel reports lecture honoraria from MSD, outside the submitted work. Conflict of Interest: Gérald Simonneau reports grants from Acceleron, Janssen, MSD; consulting fees and advisory board participation with Acceleron, Janssen, MSD, Bayer; lecture honoraria from Bayer, Janssen, MSD; travel support from Janssen; outside the submitted work. Conflict of Interest:Marc Humbert reports grants and consulting fees from Acceleron, Janssen, MSD; lecture honoraria from Janssen, MSD; advisory board participation with Acceleron, Janssen, MSD, United Therapeutics; and has an interest in Investissement d'Avenir program managed by the French National Research Agency under the grant contract ANR-18-RHUS-0006 (DESTINATION 2024); outside the submitted work. Conflict of Interest: Xavier Jaïs reports grants from Acceleron, Janssen, MSD; lecture honoraria from Janssen, MSD; travel support from Janssen; outside the submitted work. Conflict of Interest: All other authors have nothing to disclose." @default.
• W4387433067 created "2023-10-09" @default.
• W4387433067 creator A5029738332 @default.
• W4387433067 creator A5031477165 @default.
• W4387433067 creator A5034307417 @default.
• W4387433067 creator A5036242687 @default.
• W4387433067 creator A5036809654 @default.
• W4387433067 creator A5042206192 @default.
• W4387433067 creator A5055409793 @default.
• W4387433067 creator A5057443223 @default.
• W4387433067 creator A5059230276 @default.
• W4387433067 creator A5059392358 @default.
• W4387433067 creator A5060830068 @default.
• W4387433067 creator A5068274512 @default.
• W4387433067 creator A5068714209 @default.
• W4387433067 creator A5071103679 @default.
• W4387433067 creator A5077085879 @default.
• W4387433067 creator A5078054842 @default.
• W4387433067 creator A5082059107 @default.
• W4387433067 creator A5085643508 @default.
• W4387433067 creator A5085705865 @default.
• W4387433067 date "2023-10-06" @default.
• W4387433067 modified "2023-10-18" @default.
• W4387433067 title "Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension (CTEPH) with mixed anatomical lesions: a proof of concept" @default.
• W4387433067 doi "https://doi.org/10.1183/13993003.00517-2023" @default.
• W4387433067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37802632" @default.
• W4387433067 hasPublicationYear "2023" @default.
• W4387433067 type Work @default.
• W4387433067 citedByCount "0" @default.
• W4387433067 crossrefType "journal-article" @default.
• W4387433067 hasAuthorship W4387433067A5029738332 @default.
• W4387433067 hasAuthorship W4387433067A5031477165 @default.
• W4387433067 hasAuthorship W4387433067A5034307417 @default.
• W4387433067 hasAuthorship W4387433067A5036242687 @default.
• W4387433067 hasAuthorship W4387433067A5036809654 @default.
• W4387433067 hasAuthorship W4387433067A5042206192 @default.
• W4387433067 hasAuthorship W4387433067A5055409793 @default.
• W4387433067 hasAuthorship W4387433067A5057443223 @default.
• W4387433067 hasAuthorship W4387433067A5059230276 @default.
• W4387433067 hasAuthorship W4387433067A5059392358 @default.
• W4387433067 hasAuthorship W4387433067A5060830068 @default.
• W4387433067 hasAuthorship W4387433067A5068274512 @default.
• W4387433067 hasAuthorship W4387433067A5068714209 @default.
• W4387433067 hasAuthorship W4387433067A5071103679 @default.
• W4387433067 hasAuthorship W4387433067A5077085879 @default.
• W4387433067 hasAuthorship W4387433067A5078054842 @default.
• W4387433067 hasAuthorship W4387433067A5082059107 @default.
• W4387433067 hasAuthorship W4387433067A5085643508 @default.
• W4387433067 hasAuthorship W4387433067A5085705865 @default.
• W4387433067 hasConcept C126322002 @default.
• W4387433067 hasConcept C141071460 @default.
• W4387433067 hasConcept C164705383 @default.
• W4387433067 hasConcept C2777428986 @default.
• W4387433067 hasConcept C2777714996 @default.
• W4387433067 hasConcept C2780326628 @default.
• W4387433067 hasConcept C2780930700 @default.
• W4387433067 hasConcept C2994510025 @default.
• W4387433067 hasConcept C71924100 @default.
• W4387433067 hasConceptScore W4387433067C126322002 @default.
• W4387433067 hasConceptScore W4387433067C141071460 @default.
• W4387433067 hasConceptScore W4387433067C164705383 @default.
• W4387433067 hasConceptScore W4387433067C2777428986 @default.
• W4387433067 hasConceptScore W4387433067C2777714996 @default.
• W4387433067 hasConceptScore W4387433067C2780326628 @default.
• W4387433067 hasConceptScore W4387433067C2780930700 @default.
• W4387433067 hasConceptScore W4387433067C2994510025 @default.
• W4387433067 hasConceptScore W4387433067C71924100 @default.
• W4387433067 hasLocation W43874330671 @default.
• W4387433067 hasLocation W43874330672 @default.
• W4387433067 hasOpenAccess W4387433067 @default.
• W4387433067 hasPrimaryLocation W43874330671 @default.
• W4387433067 hasRelatedWork W2151398045 @default.
• W4387433067 hasRelatedWork W2266382802 @default.
• W4387433067 hasRelatedWork W2290935576 @default.
• W4387433067 hasRelatedWork W2399390788 @default.
• W4387433067 hasRelatedWork W2407142030 @default.
• W4387433067 hasRelatedWork W2598522446 @default.
• W4387433067 hasRelatedWork W2894322638 @default.
• W4387433067 hasRelatedWork W2953510553 @default.
• W4387433067 hasRelatedWork W4252347921 @default.
• W4387433067 hasRelatedWork W4283586964 @default.
• W4387433067 isParatext "false" @default.
• W4387433067 isRetracted "false" @default.
• W4387433067 workType "article" @default.